STARKS DANIEL J 4
4 · ABBOTT LABORATORIES · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Abbott (ABT) Director Daniel J. Starks Buys 10,000 Shares
What Happened
Daniel J. Starks, a director of Abbott Laboratories (ABT), made open-market purchases of a total of 10,000 ABT shares on February 4, 2026. The trades were reported on a Form 4 filed Feb 6, 2026. The transactions consist of 4,967 shares at $109.14 ($542,092) and 5,033 shares at $108.33 ($545,239), for total consideration of $1,087,331 (average ≈ $108.73 per share). These were purchases (acquisitions), which insiders often view as a more informative signal than routine sales, though motives are not disclosed.
Key Details
- Transaction date: 2026-02-04; Form 4 filed: 2026-02-06 (appears timely — within the 2-business-day window).
- Trades: 4,967 shares @ $109.14 = $542,092 (reported with weighted-average note F1); 5,033 shares @ $108.33 = $545,239 (weighted-average note F2).
- Combined: 10,000 shares for $1,087,331; avg price ≈ $108.73/share.
- Shares owned after transaction: Not specified in the provided excerpt of the filing.
- Footnotes: F1 and F2 state the reported prices are weighted averages and that the shares were executed in multiple transactions with price ranges (F1 range ≈ $108.8150–$109.5204; F2 range ≈ $107.7700–$108.7150) and that full breakdowns are available on request. F3 notes the shares are held in the Alynne Starks 2012 Irrevocable Trust, for which the reporting person is sole trustee.
Context
- Code P indicates an open-market or private purchase (here, open-market buys). Purchases by directors can signal confidence but do not prove future performance; avoid assuming motive.
- No derivative exercises, gifts, or tax-withholding events are reported in this filing excerpt.
Insider Transaction Report
Form 4
STARKS DANIEL J
Director
Transactions
- Purchase
Common shares without par value
[F1]2026-02-04$109.14/sh+4,967$542,092→ 6,733,784 total - Purchase
Common shares without par value
[F2]2026-02-04$108.33/sh+5,033$545,239→ 6,738,817 total
Holdings
- 258(indirect: By Trust)
Common shares without par value
[F3]
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.8150 to $109.5204, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.7700 to $108.7150, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F3]Held in the Alynne Starks 2012 Irrevocable Trust. The reporting person is the sole trustee of the trust.
Signature
/s/ Daniel J. Starks by Jessica H. Paik, Attorney-in-Fact|2026-02-06